Experts highlight shared responsibility for adult vaccination, identification of high-risk patients, and evidence-based timing of RZV, including before immunosuppressive therapy. Experts also discuss pharmacist led, technology enabled strategies that reduce missed RZV vaccination opportunities and support completion of the two-dose series through structured, team-based communication among the healthcare team to ensure coordinated care. To Claim CE Credit: https://bit.ly/4tTYVuy